FILTER
FILTERED INTERVIEW RESULTS
Hugo-Pierre Gagnon
PARTNER, OSLER, HOSKIN & HARCOURT LLP
Osler, Hoskin & Harcourt’s discusses its expectations for trends in the Québec mining industry as the upswing begins.
Kiril Mugerman
CEO, GÉOMÉGA RESOURCES
GéoMéga is focused on tapping into opportunities in the refining space.
Christopher Grove
PRESIDENT, COMMERCE RESOURCES
Commerce Resources is bullish about the future of the market for rare earth elements.
Frank Mariage
PARTNER, FASKEN
Fasken is one of the largest business law firms in Canada with more than 700 lawyers and agents in ten offices on four continents.
Rui Feng
CHAIRMAN AND CEO, SILVERCORP METALS INC.
Silvercorp is a low-cost silver-producing Canadian mining company with multiple mines in China.
Stan Wholley
PRESIDENT - AMERICAS, CSA GLOBAL
CSA Global provides technical and expert services, training and independent corporate advice to the mining industry.
Dany Pelletier & Serge Cotes
VICE PRESIDENT, STRUCTURING CAPITAL, ENERGY, ENVIRONMENT AND MINING & SENIOR INVESTMENT ADVISOR: FONDS DE SOLIDARITÉ FTQ.
The Fonds de solidarité FTQ is a Québec development capital organization dedicated to investing in local businesses to further economic development.
Jörgen Sjöstedt
MANAGING DIRECTOR, VOLVO GROUP PERU
Volvo Group Peru is expanding its market share in the region and increasingly focused on opportunities in the construction segment.
Ted Moses O.Q
President, SAENCAT
The Secretariat promotes sustainable relations and socio-economic alliances across the region to foster harmonious development.
Michael Gribbons
VICE PRESIDENT OF SALES AND MARKETING AND CO-FOUNDER, MAESTRO DIGITAL MINE
Maestro Digital Mine manufacturers IoT and control instrumentation for the optimization of underground mine ventilation and underground digital networks.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
